Integrating Depression Care in Acute Coronary Syndromes Care in China
I-Care
2 other identifiers
interventional
4,043
1 country
1
Brief Summary
The overall goal of this study is to develop, pilot test, implement, and evaluate a nurse-coordinated depression care model integrated into the care of Acute Coronary Syndromes (ACS) patients with rigorous assessment of feasibility, effectiveness, acceptability and cost in rural China. This study is a large multi-center, randomized clinical trial among 4,000 ACS patients from 20 rural county hospitals selected from a well-established research network across China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2014
CompletedFirst Posted
Study publicly available on registry
July 21, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedMay 21, 2018
May 1, 2018
3.3 years
July 15, 2014
May 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in mean Patient Health Questionnaire-9 (PHQ-9) score from baseline to 6 months
Changes in mean Patient Health Questionnaire-9 (PHQ-9) score from baseline to 6 months
Before patient discharge and after 6 months from discharge
Changes in mean PHQ-9 score from baseline to 12 months
Changes in mean Patient Health Questionnaire-9 (PHQ-9) score from baseline to 12 months
Before patient discharge and after 12 months from discharge
Secondary Outcomes (3)
Incidence of Major Adverse Cardiovascular Events (MACE)
At least 12 months after discharge
Proportion of patients with self-reported adherence to evidence-based Acute Coronary Syndromes (ACS) secondary prevention treatment at 6 and 12 months
At 6 and 12 months after discharge
Quality of life (EQ5D) at 6 and 12 months after discharge
At 6 and 12 months after discharge
Other Outcomes (6)
Incidence of Major Adverse Events (MACE) after discharge
At 6 month and 12 month after patients discharged from hospital
Proportion of patients with improved cardiovascular risk surrogates
At 6 month and 12 month after discharge
Proportion of patients with increased healthy life style
At 6 and 12 months after discharge
- +3 more other outcomes
Study Arms (2)
Usual Care (UC)
NO INTERVENTIONThe standard interventions from Clinical Pathway for Acute Coronary Syndromes in China-Phase 3 (CPACS-3) study that are limited to in-patient ACS care (refer to "Usual Care" \[UC\]), will be implemented in the participating hospitals, and hence will be received by all patients in both intervention (IC) and control (UC) groups; standardized cardiovascular disease education also will be provided to all participants.CPACS-3 registration number is NCT01398228
Intervention Care (IC)
EXPERIMENTALBesides of the UC, an nurse-coordinated integrated care model for Acute Coronary Syndromes(ACS) and depression will be delivered to intervention group, including ACS secondary prevention therapies at and after discharge, screening and treatment of depression during hospitalization and after discharge.
Interventions
an integrated care model for ACS and depression delivered by a collaborative team composed of cardiologists/internists and nurses in the same rural county hospital. The collaborative team will be able to provide medical services for the diagnosis and treatment at acute phase of ACS during hospitalization, ACS secondary prevention therapies at and after discharge, and screening and treatment of depression depressive symptom during hospitalization and after discharge. The core of the interventions includes: depressidepressive symptomon screening and classification, individual counseling and medical treatment of depression, group counseling and health education, and follow-up for ACS and depression treatments compliance, IT- system- assisting theassisted management and necessary referral.
Eligibility Criteria
You may qualify if:
- Age 20 to 79 years old
- Hospitalized due to a diagnosis of Acute Coronary Syndromes (ACS)
- ACS is stable (as judged by the treating cardiologist/internist)
- Signed patient informed consent
You may not qualify if:
- Affected by severe cardiovascular disease or medical comorbidity that indicate the patient's life expectancy is less than 12 months (e.g. class IV heart failure, terminal cancer)
- Seriously disabled (unable to travel to the hospital, class IV heart failure at baseline)
- Suffering from problems that affect normal communication (e.g., intellectual impairment, observed mental confusion suggesting dementia, deafness, blindness, etc.)
- Non-permanent local residents or permanent residents planning to move out within 12 months
- Pregnant or breast-feeding or planning pregnancy within 12 months
- Affected by bipolar disorder, schizophrenia or severe depression that meet criteria for referral including patients with acutely suicidal risk (Beck Depression Inventory Item9=3)
- Having alcohol dependence (defined by MINI Alcohol Dependence/Abuse Part)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The George Institute for Global Health, China
Haidian, Beijing Municipality, 100088, China
Related Publications (1)
Wu Y, Yu X, Zhu Y, Shi C, Li X, Jiang R, Niu S, Gao P, Li S, Yan L, Maulik PK, Guo G, Patel A, Gao R, Blumenthal JA. Integrating depression and acute coronary syndrome care in low resource hospitals in China: the I-CARE randomised clinical trial. Lancet Reg Health West Pac. 2024 Jul 1;48:101126. doi: 10.1016/j.lanwpc.2024.101126. eCollection 2024 Jul.
PMID: 39040037DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yangfeng Wu, MD, PhD
The Geogre Institute for Global Health, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2014
First Posted
July 21, 2014
Study Start
November 1, 2014
Primary Completion
February 1, 2018
Study Completion
February 1, 2018
Last Updated
May 21, 2018
Record last verified: 2018-05